Asthma and lower airway diseasePediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33
Key words
Abbreviations used
Cited by (0)
C.M.L. and R.J.S. were funded by the Wellcome Trust UK (grants 086718/Z/08/Z and 095707/Z/11/Z). S.S. was funded by the MRC New Investigator Research Grant (grant MR/J010529/1). A.B. is an NIHR Senior Investigator and was supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. S.S., C.M.L., and A.B. are investigators in the MRC Asthma UK Centre for Allergic Mechanisms of Disease. R.G. was funded by the German Research Foundation (GR 4379/1 1).
Disclosure of potential conflict of interest: S. Walker has received research support from the MRC/Asthma UK Centre for Asthma and Allergic Mechanisms. J. Buckley has received research support from the Wellcome Trust. R. Grychtol has received research support from the German Research Foundation. L. Fleming has received consultancy fees from Chiesi, is employed by Imperial College, London, has received research support from the Royal Brompton and Harefield NHS Trust (Biomedical Research Unit), and has received lecture fees from Novartis. R. J. Snelgrove has received research support from the Wellcome Trust. C. M. Lloyd has received research support from the Wellcome Trust, MedImmune, and Johnson & Johnson. S. Saglani has received research support from the MRC. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.